Detection of 14-3-3 protein in the cerebrospinal fluid in mitochondrial encephalopathy with lactic acidosis and stroke-like episodes

Journal of the Neurological Sciences

Volumn 239, Issue 1, 2005, Pages 115-118

  Fujii, Katsunori ^a   Tanabe, Yuzo ^b   Kobayashi, Kazuhiko ^b   Uchikawa, Hideki ^a   Kohno, Yoichi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CHILDREN'S HOSPITAL   (Japan)

Author keywords

14 3 3 protein; CSF; Immunoblotting; Isoforms; MELAS; MR study

Indexed keywords

BIOLOGICAL MARKER; PROTEIN 14 3 3;

ADOLESCENT; ARTICLE; BRAIN INJURY; CASE REPORT; CEREBROSPINAL FLUID; CORRELATION ANALYSIS; DISEASE COURSE; HUMAN; LACTIC ACIDOSIS; MALE; MELAS SYNDROME; MENTAL DETERIORATION; MITOCHONDRIAL ENCEPHALOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUADRIPLEGIA; STROKE;

14-3-3 PROTEINS; ADOLESCENT; BIOLOGICAL MARKERS; BRAIN; CEREBROVASCULAR ACCIDENT; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELAS SYNDROME; MITOCHONDRIA; PREDICTIVE VALUE OF TESTS;

EID: 27744548056     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.08.007     Document Type: Article

References (16)

1. S.G. Pavlakis, P.C. Phillips, S. DiMauro, D.C. De Vivo, and L.P. Rowland Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome Ann Neurol 16 1984 481 488
2. Y. Goto, I. Nonaka, and S. Horai A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies Nature 348 1990 651 653
3. J. Schmiedel, S. Jackson, J. Schafer, and H. Reichmann Mitochondrial cytopathies J Neurol 250 2003 267 277
4. P.R. Burkhard, J.C. Sanchez, T. Landis, and D.F. Hochstrasser CSF detection of the 14-3-3 protein in unselected patients with dementia Neurology 56 2001 1528 1533
5. D. Berg, C. Holzmann, and O. Riess 14-3-3 proteins in the nervous system Nat Rev Neurosci 4 2003 752 762
6. J. Satoh, K. Kurohara, M. Yukitake, and Y. Kuroda The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture Eur Neurol 41 1999 216 225
7. P. Giraud, A.G. Biacabe, G. Chazot, R. Later, O. Joyeux, and Y. Moene Increased detection of 14-3-3 protein in cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease during the disease course Eur Neurol 48 2002 218 221
8. J.P. Brandel, K. Peoc'h, P. Beaudry, A. Welaratne, C. Bottos, and Y. Agid 14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients Ann Neurol 49 2001 257 260
9. A.W. Lemstra, M.T. van Meegen, J.P. Vreyling, P.H. Meijerink, G.H. Jansen, and S. Bulk 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients Neurology 55 2000 514 516
10. I. Zerr, M. Bodemer, O. Gefeller, M. Otto, S. Poser, and J. Wiltfang Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease Ann Neurol 43 1998 32 40
11. M. Otto, J. Wiltfang, L. Cepek, M. Neumann, B. Mollenhauer, and P. Steinacker Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease Neurology 58 2002 192 197
12. G. Hsich, K. Kenney, C.J. Gibbs, K.H. Lee, and M.G. Harrington The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies N Engl J Med 335 1996 924 930
13. A. Martinez-Yelamos, A. Saiz, R. Sanchez-Valle, V. Casado, J.M. Ramon, and F. Graus 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis Neurology 57 2001 722 724
14. A.W. Lemstra, M.T. van Meegen, J.P. Vreyling, P.H. Meijerink, G.H. Jansen, and S. Bulk 14-3-3 testing in diagnosing Creutzfeldt-Jakob disease: a prospective study in 112 patients Neurology 55 2000 514 516
15. A. Saiz, F. Graus, J. Dalmau, A. Pifarre, C. Marin, and E. Tolosa Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders Ann Neurol 46 1999 774 777
16. D.N. Irani, and D.A. Kerr 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis Lancet 355 2000 901